Does MARS™ beneficially affect hemodynamics in refractory vasoplegic shock due to calcium-channel blocker poisoning? Evidence is missing

Abstract

Keywords

Calcium-channel blocker poisoning albumin dialysis mars hemodynamics cardiovascular failure shock refractoriness

Get full access to this article

View all access options for this article.

References

Beyls

Malaquin

Huette

, et al. Hemodynamic impact of molecular adsorbent recirculating system in refractory vasoplegic shock due to calcium channel blocker poisoning. Int J Artif Organs. Epub ahead of print 5 April 2021. DOI: 10.1177/03913988211007865.

Gérard

Galloy

A-C

Capron

, et al. Mixed amlodipine/valsartan overdose treated by the molecular adsorbent recirculating system (MARS^TM). Clin Toxicol (Phila) 2015; 53: 573–577.

Wong

Hoffman

Walsh

, et al. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 2021; 59: 361–375.

Onge

Anseeuw

Cantrell

, et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med 2017; 45: e306–e315.

Weir

Fleet

Dixon

, et al. Angiotensin converting enzyme inhibitor dialyzability and outcomes in older patients receiving hemodialysis. Blood Purif 2015; 40: 232–242.